HyperHEP B™ S/D Dosing

Indication	Dosage
Exposure to blood containing HBV	0.06 mL/kg IM within 7 days of exposure
Infants born to mothers who carry HBV	0.5 mL IM on day of birth
Sexual contact with persons who carry HBV	0.06 mL/kg IM within 14 days of last sexual contact
All other contacts	See complete prescribing information (PDF)

Product Information
Product	NDC#	Description	Size
HyperHEP B™ S/D	13533-636-03	Neonatal Single Dose Syringe (safety syringe)	0.5 mL
HyperHEP B™ S/D	13533-636-02	Single Dose Syringe (safety syringe)	1 mL
HyperHEP B™ S/D	13533-636-05	Single Dose Vial	5 mL

For more information please call Talecris Biotherapeutics Customer Service at 1-800-243-4153 or your local distributor.

For clinical or technical questions call Talecris Biotherapeutics Clinical Communications at 1-800-520-2807.

View HyperHEP B™ S/D Prescribing Information (PDF)

Find vaccine information for healthcare professionals.

Find information for the public and health professionals


Contact Talecris Glossary Site Map General Conditions of Use Privacy Statement California Compliance

© 2008 Talecris Biotherapeutics